vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and DENNY'S Corp (DENN). Click either name above to swap in a different company.
DENNY'S Corp is the larger business by last-quarter revenue ($113.2M vs $83.5M, roughly 1.4× BillionToOne, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs 0.6%, a 6.3% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 1.3%). DENNY'S Corp produced more free cash flow last quarter ($16.0M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Denny's is an American table service diner-style restaurant chain. It operates over 1,400 restaurants in the United States, Canada, México, Puerto Rico, and several other international locations.
BLLN vs DENN — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $113.2M |
| Net Profit | $5.7M | $632.0K |
| Gross Margin | 69.9% | — |
| Operating Margin | 11.5% | 9.2% |
| Net Margin | 6.8% | 0.6% |
| Revenue YoY | 117.4% | 1.3% |
| Net Profit YoY | 138.3% | -90.3% |
| EPS (diluted) | $0.10 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $83.5M | $113.2M | ||
| Q2 25 | — | $117.7M | ||
| Q1 25 | — | $111.6M | ||
| Q4 24 | $45.1M | $114.7M | ||
| Q3 24 | $38.4M | $111.8M | ||
| Q2 24 | — | $115.9M | ||
| Q1 24 | — | $110.0M | ||
| Q4 23 | — | $115.4M |
| Q3 25 | $5.7M | $632.0K | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $326.0K | ||
| Q4 24 | $-11.5M | $6.8M | ||
| Q3 24 | $-14.9M | $6.5M | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | — | $4.7M | ||
| Q4 23 | — | $2.9M |
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 11.5% | 9.2% | ||
| Q2 25 | — | 7.3% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | 17.0% | 12.6% | ||
| Q3 24 | -32.9% | 10.5% | ||
| Q2 24 | — | 7.9% | ||
| Q1 24 | — | 9.1% | ||
| Q4 23 | — | 6.7% |
| Q3 25 | 6.8% | 0.6% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | -25.5% | 5.9% | ||
| Q3 24 | -38.8% | 5.8% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 4.3% | ||
| Q4 23 | — | 2.5% |
| Q3 25 | $0.10 | $0.01 | ||
| Q2 25 | — | $0.05 | ||
| Q1 25 | — | $0.01 | ||
| Q4 24 | $-1.13 | $0.13 | ||
| Q3 24 | $-1.47 | $0.12 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $0.09 | ||
| Q4 23 | — | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | — |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $-32.7M |
| Total Assets | $327.5M | $502.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $195.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.1M | ||
| Q4 24 | $191.5M | $100.0K | ||
| Q3 24 | — | $2.9M | ||
| Q2 24 | — | $2.8M | ||
| Q1 24 | — | $2.8M | ||
| Q4 23 | — | $100.0K |
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $51.5M | $270.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $264.6M |
| Q3 25 | $-239.5M | $-32.7M | ||
| Q2 25 | — | $-34.6M | ||
| Q1 25 | — | $-36.4M | ||
| Q4 24 | $-251.7M | $-34.0M | ||
| Q3 24 | $-242.9M | $-54.5M | ||
| Q2 24 | — | $-53.2M | ||
| Q1 24 | — | $-55.7M | ||
| Q4 23 | — | $-62.7M |
| Q3 25 | $327.5M | $502.9M | ||
| Q2 25 | — | $491.1M | ||
| Q1 25 | — | $488.1M | ||
| Q4 24 | $302.1M | $496.3M | ||
| Q3 24 | — | $461.6M | ||
| Q2 24 | — | $459.9M | ||
| Q1 24 | — | $460.4M | ||
| Q4 23 | — | $464.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $16.0M |
| Free Cash FlowOCF − Capex | $6.5M | $16.0M |
| FCF MarginFCF / Revenue | 7.7% | 14.1% |
| Capex IntensityCapex / Revenue | 8.8% | 0.0% |
| Cash ConversionOCF / Net Profit | 2.42× | 25.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $13.8M | $16.0M | ||
| Q2 25 | — | $9.4M | ||
| Q1 25 | — | $5.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $6.6M | ||
| Q2 24 | — | $14.2M | ||
| Q1 24 | — | $215.0K | ||
| Q4 23 | — | $21.4M |
| Q3 25 | $6.5M | $16.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 7.7% | 14.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 8.8% | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 2.42× | 25.28× | ||
| Q2 25 | — | 3.79× | ||
| Q1 25 | — | 15.38× | ||
| Q4 24 | — | 1.26× | ||
| Q3 24 | — | 1.01× | ||
| Q2 24 | — | 3.97× | ||
| Q1 24 | — | 0.05× | ||
| Q4 23 | — | 7.36× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
DENN
| Franchisor Owned Outlet | $57.4M | 51% |
| Royalty | $27.7M | 25% |
| Advertising | $18.6M | 16% |
| Occupancy | $7.7M | 7% |
| Initial And Other Fees | $1.7M | 1% |
